BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Oct 25, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Dexmedetomidine regulatory update

The European Medicines Agency accepted for review an MAA from Orion for dexmedetomidine for intensive care sedation. The company expects the...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >